Rohit Shishodia

Sun Pharma, one of India's top pharmaceutical companies, launched a  novel formulation in cough management - Chericof® 12 (Dextromethorphan  Hydrobromide 30 mg and Chlorpheniramine Maleate 4 mg) in India.

“Chericof® 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is  manufactured using Polistirex technology for sustained release of the drug. Chericof®
12 is approved for patients of age group six years and above,” said Sun Pharma in a press release on September 28,2021.

The pharma firm said that all cough syrups generally give relief for 6-8 hours, and hence a patient has to take it three to four times a day. Frequent dosing often leads to patient inconvenience and  non-adherence to follow the regimen, which may compromise the efficacy of the  and disturb the daily lifestyle.

As per a study, a twice-a-day dosing regimen was associated with significantly better compliance in 70% of patients than three- times a day (52%) and four-times a day (42%) dosing regimen, respectively1.

The Polistirex technology used in Chericof® 12 provides sustained release of the medicine  in the body, thus offering up to 12 hour relief to patients with twice-daily dosage.

Kirti Ganorkar, CEO – India Business, Sun Pharma said “At Sun Pharma, we always  endeavour to introduce differentiated medicines that enhance convenience or solve  patients’ problems, thus helping them to cope better with their ailments. The Polistirex technology used in Chericof® 12 helps in improving patient compliance and avoids the need for frequent dosing.”